VOYA INVESTMENT MANAGEMENT LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1068837
ATLANTA, GA
Position in GLUE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,790,518
+$2,436,043 QoQ
Shares Held
156,633
+90.2% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 193 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0%
Shared 56%
None 44%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. GLUE ranks #50 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in GLUE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,790,518 | 156,633 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,354,475 | 82,339 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $413,669 | 26,382 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $58,440 | 12,958 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $53,884 | 11,613 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $84,425 | 12,165 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $69,546 | 13,122 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $41,712 | 11,153 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $74,433 | 10,558 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $70,427 | 12,465 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $444,655 | 92,830 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $635,885 | 92,830 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $719,234 | 92,328 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $702,615 | 92,328 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $810,479 | 99,202 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $100,858 | 10,430 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $1,947,147 | 95,355 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,290,851 | 102,821 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,364,817 | 104,177 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||